Oxyepiberberine from the Active Site of Coptidis Rhizoma Inhibits Lung Adenocarcinoma by Regulating SRC-related Pathways in vivo
Article in Pharmacognosy Magazine (February 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Pharmacognosy Magazine (February 2024)
Article in Chinese Journal of Lasers (January 2024)
Article in American Journal of Cancer Research (November 2023)